Peer-reviewedCC BYFrontiers in nephrology
Gd-IgA1-targeting therapy in IgA nephropathy ~what is pathogenic Gd-IgA1?~
- 1Department of Nephrology, Juntendo University Faculty of Medicine , ,
Related
- Targeting the NLRP3 inflammasome in rheumatoid arthritis fibroblast-like synoviocytes: pathogenic mechanisms, therapeutic strategies, and translational perspectives
- AT1R-Selective Negative Allosteric Modulator Targeting the Epitope for Pathogenic Autoantibody Activation
- Hybrid Molecular Lateral Flow Assay Targeting the lipL32 Gene for Rapid and Highly Sensitive Detection of Pathogenic Leptospira
- Glomerular Properdin Deposition Suggests a Favorable Therapeutic Response to Tonsillectomy and Steroid Pulse Therapy in IgA Nephropathy
- Sustained remission of NELL-1-positive membranous nephropathy after lung adenocarcinoma resection and during subsequent atezolizumab therapy in a 68-year-old man: a case report
BibTeX
@article{mori2026gdiga1targeting,
title = {{Gd-IgA1-targeting therapy in IgA nephropathy ~what is pathogenic Gd-IgA1?~}},
author = {Kazuaki Mori and Yoshihito Nihei and Yusuke Suzuki},
journal = {Frontiers in nephrology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13669562},
note = {CC BY},
}
RIS
TY - JOUR
TI - Gd-IgA1-targeting therapy in IgA nephropathy ~what is pathogenic Gd-IgA1?~
AU - Kazuaki Mori
AU - Yoshihito Nihei
AU - Yusuke Suzuki
PY - 2026
DA - 2026/10/19
JO - Frontiers in nephrology
UR - https://europepmc.org/article/PMC/PMC13669562
SN - 2813-0626
ER -